PMID- 34136710 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210619 IS - 2434-0790 (Electronic) IS - 2434-0790 (Linking) VI - 3 IP - 6 DP - 2021 May 26 TI - Left Ventricular Hypertrophic Change Indicating Poor Prognosis in Patients With Normal-Flow, Low-Gradient Severe Aortic Stenosis With Preserved Left Ventricular Ejection Fraction. PG - 345-353 LID - 10.1253/circrep.CR-21-0011 [doi] AB - Background: Risk stratification of normal-flow, low-gradient (NFLG) severe aortic stenosis (SAS) with preserved left ventricular (LV) ejection fraction (EF) remains unclear. Methods and Results: Of 289 consecutive patients diagnosed with SAS by aortic valve area <1.0 cm(2), 66 with NFLG-SAS (stroke volume index >35 mL/m(2), mean pressure gradient <40 mmHg, LVEF >/=50%) were enrolled in this study; patients with bicuspid aortic valve, acute coronary syndrome, hemodialysis, or a history of aortic valve replacement (AVR) were excluded. Adverse events (AEs) were defined as cardiovascular death, hospitalization for heart failure, and deteriorating condition requiring AVR. Factors associated with AEs were investigated using a Cox proportional hazards model. Over a median of 675 days of follow-up, 25 AEs were recorded: 4 cardiovascular deaths, 12 hospitalizations for heart failure, and 9 patients requiring AVR. In addition, there were 14 events of progression to high-gradient SAS. Multivariable analysis showed significant associations between AEs and the presence of symptoms (hazard ratio [HR] 10.276; 95% confidence interval [CI] 3.724-28.357; P<0.001), LV hypertrophy (LV mass index >115 and >95 mg/m(2) for males and females, respectively; HR 3.257; 95% CI 1.172-9.050; P=0.024), and tricuspid regurgitation (TR) velocity (HR 2.761; 95% CI 1.246-6.118; P=0.012). Conclusions: The presence of symptoms, LV hypertrophy, and high TR velocity could be reliable prognostic indicators and may require watchful waiting for timely AVR in patients with NFLG-SAS. CI - Copyright (c) 2021, THE JAPANESE CIRCULATION SOCIETY. FAU - Kawada, Yu AU - Kawada Y AD - Department of Cardiology, Nagoya City University Graduate School of Medical Sciences Nagoya Japan. FAU - Kitada, Shuichi AU - Kitada S AD - Department of Cardiology, Nagoya City University Graduate School of Medical Sciences Nagoya Japan. FAU - Hachiya, Kenta AU - Hachiya K AD - Division of Cardiology, Nagoya City University East Medical Center Nagoya Japan. FAU - Kato, Marina AU - Kato M AD - Department of Cardiology, Nagoya City University Graduate School of Medical Sciences Nagoya Japan. FAU - Nakasuka, Kosuke AU - Nakasuka K AD - Department of Cardiology, Nagoya City University Graduate School of Medical Sciences Nagoya Japan. FAU - Kikuchi, Shohei AU - Kikuchi S AD - Department of Cardiology, Nagoya City University Graduate School of Medical Sciences Nagoya Japan. FAU - Seo, Yoshihiro AU - Seo Y AD - Department of Cardiology, Nagoya City University Graduate School of Medical Sciences Nagoya Japan. FAU - Ohte, Nobuyuki AU - Ohte N AD - Department of Cardiology, Nagoya City University Graduate School of Medical Sciences Nagoya Japan. LA - eng PT - Journal Article DEP - 20210526 PL - Japan TA - Circ Rep JT - Circulation reports JID - 101746642 PMC - PMC8180370 OTO - NOTNLM OT - Left ventricular hypertrophy OT - Normal-flow, low-gradient severe aortic stenosis OT - Preserved left ventricular ejection fraction OT - Prognosis COIS- Y.S. is a member of Circulation Reports' Editorial Team. The authors have no financial relationship with any commercial entity that has an interest in the subject of this manuscript, and all authors declare no potential conflicts of interest. EDAT- 2021/06/18 06:00 MHDA- 2021/06/18 06:01 PMCR- 2021/05/26 CRDT- 2021/06/17 06:50 PHST- 2021/06/17 06:50 [entrez] PHST- 2021/06/18 06:00 [pubmed] PHST- 2021/06/18 06:01 [medline] PHST- 2021/05/26 00:00 [pmc-release] AID - 10.1253/circrep.CR-21-0011 [doi] PST - epublish SO - Circ Rep. 2021 May 26;3(6):345-353. doi: 10.1253/circrep.CR-21-0011.